ABSTRACT
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to potentially life-threatening complications such as ventricular rupture, cardiac tamponade, and circulatory failure. We present a case series of patients with lymphoma and cardiomyopathy or cardiac metastasis managed with chimeric antigen receptor T-cell therapy. (Level of Difficulty: Advanced.).
PMID:37283829 | PMC:PMC10240233 | DOI:10.1016/j.jaccas.2023.101840
13:46
Photo
Not included, change data exporting settings to download.
1200×1200, 39.0 KB
13:46
In reply to this message
PubMed articles on: Cardio-Oncology
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
Curr Oncol Rep. 2023 Jun 6. doi: 10.1007/s11912-023-01428-y. Online ahead of print.
No comments:
Post a Comment
اكتب تعليق حول الموضوع